CORT Competitors
Corcept Therapeutics Incorporated
$107.50
-$8.78(-7.55%)
48
Overall
25
Value
66
Tech
55
Quality
Market Cap
$12.57B
Volume
737.29K
52W Range
$28.66 - $126.38
Target Price
$139.67
CORT competitors: JNJ, BMY, NVS, LLY, PFE. Corcept Therapeutics Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
CORT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| JNJ Johnson & Johnson | $268.77 | $621.22B | $11.12 | 1.96% | 56 |
| BMY Bristol-Myers Squibb Company | $63.01 | $124.85B | $6.56 | 4.00% | 69 |
| NVS Novartis AG | $156.27 | $293.72B | $8.91 | 3.05% | 67 |
| LLY Eli Lilly and Company | $1306.69 | $1.20T | $33.56 | 0.51% | 68 |
| PFE Pfizer Inc. | $30.40 | $170.14B | $2.95 | 5.66% | 79 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CORT | $107.50 | -7.6% | 737.29K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corcept Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW